Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Shin Maeda, Satoshi Moriya et al.|Hepatology Research|2021Cited by 50
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Shin Maeda, Manabu Morimoto et al.|The Oncologist|2023Cited by 42
Relationship between response to lusutrombopag and splenic volumeHaruki Uojima, Wasaburo Koizumi, Yoshitaka Arase et al.|World Journal of Gastroenterology|2018Cited by 25
Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell InfiltrationYoshitaka Arase, Tatehiro Kagawa, Koshi Matsumoto et al.|Digestive Diseases|2020Cited by 19
Usefulness of autotaxin for the complications of liver cirrhosisXue Shao, Wasaburo Koizumi, Haruki Uojima et al.|World Journal of Gastroenterology|2020Cited by 18